The Supreme Court Today (May 7th) questioned the Central government’s directive to AYUSH authorities, asking why they were instructed not to act against misleading advertisements under Rule 170 of the Drugs and Cosmetics Rules, 1945. The inquiry came during a hearing of a plea filed by the Indian Medical Association (IMA) against an alleged smear campaign by Patanjali Ayurved and its founders Baba Ramdev and Acharya Balkrishna, targeting the COVID-19 vaccination drive and modern medicine.
Today, 10th April, The Supreme Court
scolded Uttarakhand’s drug licensing authority for failing to act against Patanjali Ayurved’s misleading ads, suspending three officers. The court also criticized Patanjali’s founders and the central AYUSH Ministry for not intervening. This follows a petition by the Indian Medical Association over misleading claims against COVID-19 and vaccines.
